
CAS 1242137-18-3
:Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-2,4-dioxo-1-imidazolidinyl]-2-fluoro-N-methyl-
Description:
Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-2,4-dioxo-1-imidazolidinyl]-2-fluoro-N-methyl- is a complex organic compound characterized by its unique structural features, including a benzamide core and multiple functional groups. The presence of a cyano group and trifluoromethyl substituent indicates potential applications in pharmaceuticals and agrochemicals, as these groups can enhance biological activity and lipophilicity. The imidazolidinyl moiety contributes to the compound's potential as a bioactive agent, possibly influencing its interaction with biological targets. Additionally, the fluorine atoms may impart increased metabolic stability and altered solubility properties. The compound's molecular structure suggests it may exhibit interesting chemical reactivity and stability under various conditions. Its specific properties, such as melting point, solubility, and reactivity, would depend on the overall molecular interactions and the environment in which it is studied. As with many complex organic compounds, further research would be necessary to fully elucidate its characteristics and potential applications.
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 4 products.
Oxo Enzalutamide
CAS:Formula:C21H16F4N4O3Color and Shape:White To Off-White SolidMolecular weight:448.38Oxo-MDV 3100 (Oxo-enzalutamide)
CAS:Controlled Product<p>Applications Oxo-MDV 3100 (Oxo-enzalutamide) is an impurity of Enzalutamide (M199800), which is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. Enzalutamide has been shown to induce tumor cell apoptosis, and is used for the treatment of castration-resistant prostate cancer.<br>References Scher, H.I. et al.: Lancet, 375, 1437 (2010); Bellmunt, J. et al.: Ther. Adv. Med. Oncol., 2, 189 (2010); Ryan, C.J. et al.: J. Clin. Oncol., 29, 3651 (2011); Ma, X., et al.: J. Pharm. Biomed. Anal., 131, 436 (2016);<br></p>Formula:C21H16F4N4O3Color and Shape:NeatMolecular weight:448.37Oxo-MDV 3100-d3 (Oxo-enzalutamide-d3)
CAS:Controlled ProductFormula:C21D3H13F4N4O3Color and Shape:NeatMolecular weight:451.389


